Takeda shareholders approve $59 billion Shire buy but are wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

from Reuters: Business News https://ift.tt/2QFWc9o